Public Awareness of Personalized Medicine Not Growing in Step With Industry, Survey Shows

May 23, 2018

|

NEW YORK (GenomeWeb) – Despite the rapid expansion of the genetic testing industry, more consumers ordering genetic testing online, and the growing list of molecularly informed personalized treatments, genetics and personalized medicine are not top of mind for the general public in the US.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

A 'Double Whammy'

The Guardian reports that the Mammalian Genetics Unit at the Harwell Institute is to close.

So Much Plastic

Scientific research itself contributes to plastic waste and isn't very sustainable, FiveThirtyEight reports.

With a Little Lemon?

Restaurants in the US may soon serve AquaBounty's genetically modified salmon, according to the Associated Press.

Science Has a Trio of Ruminant Genome Studies and More

In Science this week: three studies from the Ruminant Genome Project, and more.

Featured White Papers

BlueBee Data Security & Compliance

Epigenomic Analysis of Sorted Retinal Ganglion Cells using ATAC-seq

Type 1 Interferon Gene Expression Analysis: Precision Medicine in Lupus

Jun

25

Featured Webinar

Error-Corrected Sequencing to Detect Measurable Residual Disease in Post-Transplant MDS Cases

Jul

23

Featured Webinar

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients.

Jul

24

Featured Webinar

Comparison of Group B Streptococcus Molecular Assays for Routine Screening in Pregnant Women

This webinar will share the results of comparisons of commercially available nucleic acid amplification tests for use in routine screening of pregnant women for Group B Streptococcus (GBS).

Jul

25

Featured Webinar

Cell-free DNA Testing for Fetal Aneuploidy: Lessons Learned and Implications for Clinical Practice

This webinar will discuss the evolution of fetal aneuploidy screening and the most recent evidence around the implementation of prenatal cell-free DNA testing in clinical practice.

Menu